Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Antimicrob Agents Chemother
1 Antiviral Res
1 Drug Saf
1 J Immunol
1 J Virol Methods
3 PLoS One
4 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antimicrob Agents Chemother

  1. STAROSILA D, Rybalko S, Varbanetz L, Ivanskaya N, et al
    Anti-influenza activity of Bacillus subtilis probiotic strain.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00539.
    PubMed     Text format     Abstract available

    Antiviral Res

  2. WANG M, Wang S, Wang W, Wang Y, et al
    Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
    Antiviral Res. 2017;143:74-84.
    PubMed     Text format     Abstract available

    Drug Saf

  3. DOS SANTOS G, Seifert HA, Bauchau V, Shinde V, et al
    Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt.
    Drug Saf. 2017 Apr 17. doi: 10.1007/s40264-017-0532.
    PubMed     Text format     Abstract available

    J Immunol

  4. ZHANG H, Luo J, Alcorn JF, Chen K, et al
    AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality.
    J Immunol. 2017 Apr 19. pii: 1600714. doi: 10.4049/jimmunol.1600714.
    PubMed     Text format     Abstract available

    J Virol Methods

  5. JIA W, Cao C, Lin Y, Zhong L, et al
    Detection of a novel highly pathogenic H7 influenza virus by duplex real-time reverse transcription polymerase chain reaction.
    J Virol Methods. 2017 Apr 11. pii: S0166-0934(17)30124.
    PubMed     Text format    

    PLoS One

  6. VERMA S, Soto J, Vasudevan A, Schmeisser F, et al
    Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    PLoS One. 2017;12:e0175733.
    PubMed     Text format     Abstract available

  7. DANNEMILLER NG, Webb CT, Wilson KR, Bentler KT, et al
    Impact of body condition on influenza A virus infection dynamics in mallards following a secondary exposure.
    PLoS One. 2017;12:e0175757.
    PubMed     Text format     Abstract available

  8. SACZYNSKA V, Romanik A, Florys K, Cecuda-Adamczewska V, et al
    Correction: A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies.
    PLoS One. 2017;12:e0176249.
    PubMed     Text format     Abstract available


    Advancing new vaccines against pandemic influenza in low-resource countries.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30446.
    PubMed     Text format     Abstract available

  10. DAUNER A, Agrawal P, Salvatico J, Tapia T, et al
    The in vitro MIMIC(R) platform reflects age-associated changes in immunological responses after influenza vaccination.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30451.
    PubMed     Text format     Abstract available

  11. SUH J, Kim B, Yang Y, Suh DC, et al
    Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30480.
    PubMed     Text format     Abstract available

  12. VAN DOORN E, Darvishian M, Dijkstra F, Donker GA, et al
    Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30476.
    PubMed     Text format     Abstract available

    Virus Res

  13. FULTON RW, Neill JD, Saliki JT, Landis C, et al
    Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
    Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.